United States · FDA National Drug Code directory
Mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-0248_cf56cd8c-e0aa-ae8b-38fe-396561abe6bf
- Product NDC
- 60505-0248
- Form
- TABLET, FILM COATED
- Composition / generic term
- Mirtazapine
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070822
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRTAZAPINE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (60505-0248-1) · 60505-0248-1
- 100 TABLET, FILM COATED in 1 BOTTLE (60505-0248-3) · 60505-0248-3
- 500 TABLET, FILM COATED in 1 BOTTLE (60505-0248-5) · 60505-0248-5
- 1000 TABLET, FILM COATED in 1 BOTTLE (60505-0248-8) · 60505-0248-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →